| Printer Friendly Click to print this page| Add to Favorites Click to add to favorites| Font Size
:
HOME FAQ CONTACT US LINKS SITEMAP MEDCOM ARMY.MIL AKO

Frequently Asked Questions

    Symbol for information
  1. In general, how do US Servicemembers receive the capabilities they need to accomplish the Nation’s military demands in the new and emerging global environment?

    Chapter 11 of How the Army Runs details the process of Material System Research, Development and Acquisition Management in the Army. If you wish to learn more in detail, various courses are offered by the Defense Acquisition University in various fields of integrated DoD acquisition and lifecycle management.


  2. I have a medical product that the Army may be interested in, how can I get it in the hands of US Service members for use in the field?


  3. If you have an idea or medical product that you think can support our servicemen and women, please go to the US Army Medical Research and Materiel Command (USAMRMC) New Products and Ideas (NPI) website. Unsolicited proposals allow unique and innovative products or ideas that have been developed outside the Government to be made available to Government agencies for use in accomplishment of their missions. Unsolicited proposals are offered with the intent that the Government will enter into a contract with the offeror for research and development or other efforts supporting the Government mission, and often represent a substantial investment of time and effort by the offeror.

  4. Typically advanced product development in the DoD involves the materiel developer and the combat developer, which do you represent?


  5. USAMMDA is the Medical Material Developer for the US Army, and product and program managers work closely with the combat developer at the Army Medical Department Center and Schools (AMEDD C&S) Directorate of Combat Doctrine and Development (DCDD).

  6. What process does USAMMDA employ to prioritize funding for advanced product development?


  7. USAMMDA developed and employs a Decision Gate model to apply proven business techniques to USAMRMC programs to conserve resources and speed medical products to all U.S. Forces.  This effort was designed to more effectively bridge the gap from research and development to advanced product development.  Decision Gate provides a structured process to evaluate the relative maturity of mission-oriented products in development.  The process provides a rational approach to prioritize the advancement of products through development stages.

  8. How does USAMMDA work with other USAMRMC activities?


  9. Products being developed by USAMRMC laboratories are evaluated by USAMMDA for advanced development. Product managers at USAMMDA work with the laboratories to guide the advanced development. Regulatory affairs scientists and specialists at USAMMDA provide regulatory guidance to the laboratories for product development and testing requirements needed for FDA approval. Regulatory submissions are prepared by USAMMDA subject matter experts working with the laboratories and clinical studies are monitored at least three times for regulatory compliance. USAMMDA also works with USAMMA and the AMEDD Center and School to acquire and field products.

  10. How has USAMMDA provided assistance to the Warrior during Operation Iraqi Freedom and Operation Enduring Freedom (OIF/OEF)?


  11. Many of the products developed and provided by USAMMDA have benefited the wounded Warrior in Iraq and Afghanistan. Some of the products have first been tested and used in the OIF/OEF theaters. USAMMDA’s continual involvement in developing the up-armored high-mobility multipurpose wheeled vehicle (HMMWV) CASEVAC conversion kit and the MRAP vehicle casualty evacuation conversion kit have helped to produce and field more than 5,300 casualty evacuation conversion kits in support of OIF/OEF. USAMMDA has worked with military and commercial partners to produce an MRAP ambulance capable of performing medical evacuation (MEDEVAC) of wounded Warriors anywhere in theater. More than 800 MRAP ambulances have been fielded in Iraq and Afghanistan. The growing and widespread use of improvised explosive devises on the battlefield in Iraq has created the need for safer and more efficient MEDEVAC and CASEVAC methods in the field. Particularly notable accomplishments are the CATS Tourniquet, WALK and IFAK as they involve the collaboration of users, requirements developers, materiel developers, and contracting.

  12. Help! How do I find what I'm looking for?


  13. Use one of the following methods to find things on this site: -Browse through the menu on the left -Look in the Site Index in the upper right corner -Go to Organization and select the section of the Organization relevant to your needs -Use the search engine on the left to search the web content If what you are looking for is not on the web site and you believe it should be, please contact the USAMMDA Webmaster.
Last Modified Date: 08-Apr-2010